Cargando…

User vs. software-dependent variability of ELISPOT counts obtained from ten different laboratories

Detalles Bibliográficos
Autores principales:	Ansari, Tameem, Karulin, Alexey, Lehmann, Paul V, Sundararaman, Srividya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990961/ http://dx.doi.org/10.1186/2051-1426-1-S1-P95

Ejemplares similares

High Reproducibility of ELISPOT Counts from Nine Different Laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2015)

Log-Normal ELISPOT spot size distribution permits count harmonization among different laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2014)

ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting
por: Karulin, Alexey Y., et al.
Publicado: (2015)

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells
por: Hanson, Jodi, et al.
Publicado: (2015)

Normal Distribution of CD8+ T-Cell-Derived ELISPOT Counts within Replicates Justifies the Reliance on Parametric Statistics for Identifying Positive Responses
por: Karulin, Alexey Y., et al.
Publicado: (2015)

ELISPOTs produced by CD8 and CD4 cells follow log normal size distribution
por: Ghosh, Jaya, et al.
Publicado: (2013)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
por: Anthony, Donald D., et al.
Publicado: (2012)

Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity
por: Wunsch, Marie, et al.
Publicado: (2015)

High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity
por: Welter, Anna, et al.
Publicado: (2018)

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories
por: Gill, Dilbinder K., et al.
Publicado: (2010)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

Reagent Tracker Dyes Permit Quality Control for Verifying Plating Accuracy in ELISPOT Tests
por: Lehmann, Alexander, et al.
Publicado: (2018)

Ten million and counting
por: Hanlon, Vincent
Publicado: (2023)

A user-friendly software to easily count Anopheles egg batches
por: Mollahosseini, Ali, et al.
Publicado: (2012)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi
por: Jin, Chenggang, et al.
Publicado: (2013)

Virtual Global Transplant Laboratory Standard Operating Protocol for Donor Alloantigen-specific Interferon-gamma ELISPOT Assay
por: Carroll, Robert, et al.
Publicado: (2016)

Does the number of apoptotic cells in PBMC reveal the extent of impairment in T cell functionality?
por: Sundararaman, Srividya, et al.
Publicado: (2013)

Imaging-based, non-radioactive measurements of natural killer cell activity provides comparable results as classic chromium release assays but with fewer cells and less labor
por: Sundararaman, Srividya, et al.
Publicado: (2014)

Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
por: Hill, Philip C, et al.
Publicado: (2007)

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
por: Maecker, Holden T, et al.
Publicado: (2005)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
por: Kalyuzhny, Alexander E.
Publicado: (2011)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
por: Kuerten, Stefanie, et al.
Publicado: (2012)

Utility of Multi-target Nested PCR and ELISPOT Assays for the Detection of Paucibacillary Leprosy: A Possible Conclusion of Clinical Laboratory Misdiagnosis
por: Jiang, Haiqin, et al.
Publicado: (2022)

Ten recommendations for software engineering in research
por: Hastings, Janna, et al.
Publicado: (2014)

Four color B cell immunospot assays for simultaneous detection of all four immunoglobulin classes and subclasses
por: Caspell, Richard, et al.
Publicado: (2014)

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
por: Aiken, Alexander M, et al.
Publicado: (2006)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

How frequently are predicted peptides actually recognized by CD8 cells?
por: Sundararaman, Srividya, et al.
Publicado: (2013)

Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay
por: Wunsch, Marie, et al.
Publicado: (2015)

How frequently are predicted peptides actually recognized by CD8 cells?
por: Moldovan, Ioana, et al.
Publicado: (2016)

Building software teams: ten best practices for effective software development
por: Visser, Joost
Publicado: (2016)

Ten simple rules for documenting scientific software
por: Lee, Benjamin D.
Publicado: (2018)

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis
por: Sibley, Laura S., et al.
Publicado: (2012)

Defining ELISpot cut-offs from unreplicated test and control wells
por: Alexander, Neal, et al.
Publicado: (2013)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
por: Zitzner, Jennifer R., et al.
Publicado: (2012)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
por: Janetzki, Sylvia, et al.
Publicado: (2014)

How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
por: Lima-Junior, Josué da Costa, et al.
Publicado: (2017)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
por: Nowacki, Tobias M., et al.
Publicado: (2012)

VersaCount: customizable manual tally software for cell counting
por: Kim, Charles C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gmv7en38kuglsmn53k22fk988b